Home » Topics » Science » New compound

New compound
RSS

ALRT announces new additions to the product pipeline

Jan. 9, 1997

German investigators present potent dopamine D1 antagonist

Jan. 3, 1997

Nonsteroidal 5alpha-reductase inhibitors reported by Kyowa Hakko

Dec. 24, 1996

Lilly describes potential antirhinoviral compounds

Dec. 24, 1996

5-LO inhibitor under evaluation at SKB

Dec. 19, 1996

NK1 receptor antagonist synthesized by RPR

Dec. 19, 1996

DuPont Merck developing atypical antipsychotic

Dec. 19, 1996

DuPont Merck reports ester prodrugs for glaucoma

Dec. 19, 1996

Innapharma reports novel antidepressant

Dec. 19, 1996

New bile acid transporter inhibitors in preclinical testing at Searle

Dec. 16, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 14, 2025.
European VCs optimistic for med-tech exit opportunities in 2025
BioWorld MedTech
To say that European investors are optimistic about the outlook for the med-tech sector in 2025 is an understatement. A couple of companies are already listed on...
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for February 14, 2025
European VCs bullish on med-tech investments in 2025
BioWorld MedTech
European companies looking for capital should find the fundraising environment more favorable in 2025. Private med-tech financings in January totaled about $2...
Kura/Kyowa Kirin’s ziftomenib hits phase II endpoints in AML
BioWorld
Kura Oncology Inc. and Kyowa Kirin Co. Ltd.’s selective oral menin inhibitor, ziftomenib, met the primary endpoints in the phase II registrational Komet-001 trial...